A groundbreaking advancement in cartilage regeneration has emerged from an interdisciplinary team of researchers based in Lithuania, offering hope for…
Boehringer Ingelheim and Amgen have both canned early-stage immunology candidates after the prospects showed little clinical promise. Boehringer has halted…